Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy
- PMID: 30604373
- PMCID: PMC7883399
- DOI: 10.1007/s10620-018-5433-5
Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy
Erratum in
-
Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy.Dig Dis Sci. 2020 Feb;65(2):668. doi: 10.1007/s10620-019-05953-4. Dig Dis Sci. 2020. PMID: 31792670
Abstract
Introduction: Limitations in inflammatory bowel disease (IBD) care necessitate greater patient activation and self-efficacy, measures associated with positive health outcomes.
Methods: We assessed change in patient activation and general self-efficacy from baseline to 12 months through our TELEmedicine for IBD trial, a multicenter, randomized controlled trial consisting of a web-based monitoring system that interacts with participants via text messaging. A total of 222 adults with IBD who had experienced an IBD flare within 2 years prior to the trial were randomized into either a control arm that received standard care (SC) or an intervention arm that completed self-testing through the TELE-IBD system every other week (EOW) or weekly (W).
Results: Changes in self-efficacy scores were not significantly different between control and experimental groups. Patient activation scores were significantly different between standard care and the TELE-IBD EOW group only (p = 0.03).
Conclusions: Use of remote monitoring did not improve self-efficacy or patient activation compared to routine care.
Keywords: Inflammatory bowel disease; Patient activation; Self-efficacy; Telemedicine.
Conflict of interest statement
Figures
References
-
- Dahlhamer JM. Prevalence of inflammatory bowel disease among adults aged ≥ 18 years—United States, 2015: MMWR. Morbidity and mortality weekly report; 2016;65. - PubMed
-
- Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–1794. - PubMed
-
- Altschuler A, Collins B, Lewis JD, et al. Gastroenterologists’ attitudes and self-reported practices regarding inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:992–999. - PubMed
-
- Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient non-adherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003;98:1535. - PubMed
-
- Jackson CA, Clatworthy J, Robinson A, Horne R. Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol. 2010;105:525. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
